Moderna: Vaccine data in 6-11 years olds positive
Moderna Inc. announced on Monday that the results from the Phase 2/3 study of its COVID-19 vaccine in children aged between 6 and 11 years came back positive.
“We are encouraged by the immunogen…
Harry T. Partner's Academy & fpmarkets
NOI SIAMO UN GRUPPO DI LAVORO PER QUESTO NON TI CHIEDIAMO SOLDI. CON NOI NON SARAI SOLO
